...
首页> 外文期刊>Biomacromolecules >II.Release of leuprolide heterostereocomplexes prepared from D-PLA and L-PLA and leuprolide.
【24h】

II.Release of leuprolide heterostereocomplexes prepared from D-PLA and L-PLA and leuprolide.

机译:II。由D-PLA和L-PLA和亮丙瑞林制备的亮丙瑞林杂立体复合物的释放。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reversible stereoselective complexes were spontaneously obtained from mixing acetonitrile solutions of enatiomeric D-poly(lactic acid) (D-PLA),L-poly(lactic acid) (L-PLA),and leuprolide,a L-configured nonapeptide LHRH analogue.The complex spontaneously aggregated and precipitated in high yields (>90%) from acetonitrile solution,forming uniform,porous microparticles.The stereocomplex microparticles showed a continuous release of the interlocked peptide for a period of one to three months under physiological conditions.Various factors,including method of complex formation,molecular weight of PLA,leuprolide:polymer and D-PLA:L-PLA complex ratios,and additives,influenced the release pattern of leuprolide from the stereocomplexes.Continuous release of leuprolide for over 100 days was observed for certain stereocomplex compositions.In vivo evaluation of the leuprolide loaded stereocomplexes in rats by monitoring testosterone levels in the blood of rats after subcutaneous injection showed low testosterone levels for over 42 days.
机译:通过将对映体D-聚乳酸(D-PLA),L-聚乳酸(L-PLA)和亮丙立德(一种L-构型的非肽LHRH类似物)的乙腈溶液混合,可自发获得可逆的立体选择性配合物。复合物自乙腈溶液中以高收率(> 90%)自发聚集并沉淀,形成均匀的多孔微粒。立体复合物微粒在生理条件下显示出互锁肽的连续释放状态,持续1-3个月。各种因素包括配合物的形成方法,PLA的分子量,亮丙瑞林:聚合物和D-PLA:L-PLA的配合比和添加剂影响了亮丙瑞林从立体配合物中的释放方式。对于某些立体配合物,持续观察到亮丙瑞林连续释放100天以上皮下注射后通过监测大鼠血液中睾丸激素的水平对大鼠体内亮丙瑞林负载的立体复合物的体内评价显示较低睾丸激素水平超过42天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号